Extreme HypoFractionated Radiotherapy (EHFRT)

Topic Status Incomplete

Extreme HypoFractionated Radiotherapy (EHFRT) for localised prostate cancer



Health Technology Wales researchers searched for evidence on the effectiveness of extreme hypofractionated radiotherapy (EHFRT) for localised prostate cancer. Based on the evidence identified, HTW’s Assessment Group concluded to progress this topic to a full evidence appraisal.

Topic Exploration Report

TER244 (05.21)

View PDF

Access our guidance

Our advice documents are free to download, but we would be grateful if you could help us improve our services by telling us why you are looking at our advice and how you intend to use it.
  • We may like to contact you by email to find out more about how you used the documents.

  • This field is for validation purposes and should be left unchanged.